Analyst Price Targets — DNA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 25, 2025 11:43 am | — | BTIG | $9.00 | $12.05 | TheFly | Ginkgo Bioworks price target raised to $9 from $6 at BTIG |
| August 23, 2024 7:02 am | Mark Massaro | BTIG | $7.00 | $8.30 | TheFly | Ginkgo Bioworks price target lowered to $7 from $8 at BTIG |
| November 29, 2022 4:38 am | — | Berenberg Bank | $6.00 | $1.84 | Benzinga | Berenberg Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $6 |
| August 16, 2022 9:33 am | — | BTIG | $6.00 | $3.74 | Benzinga | BTIG Maintains Buy on Ginkgo Bioworks Holdings, Raises Price Target to $6 |
| June 16, 2022 9:07 am | — | Jefferies | $4.35 | $2.59 | Benzinga | Jefferies Maintains Buy on Ginkgo Bioworks Holdings, Lowers Price Target to $4.35 |
| March 3, 2022 12:00 am | Steven Mah | Cowen & Co. | $12.00 | $3.86 | Pulse 2.0 | Ginkgo Bioworks, Inc. (DNA) Stock: $12 Price Target And Outperform Rating |
Latest News for DNA
Gene-editing is a handy tool for developing sophisticated medicines. A new CRISPR molecule can destroy cells that express specific signals.
SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™…
Taipei, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced that its affiliate, EG BioMed US Inc., a Delaware corporation (“EG BioMed US”), has obtained out-of-state clinical laboratory licenses in Rhode Island and Pennsylvania for its…
A new biosecurity theme is emerging, and Palantir is leveraging it as an opportunity. Here's why that divide could matter for investors.
FTAI Aviation is innovatively leveraging jet engine cores to address the urgent power needs of data centers amid an energy bottleneck. FTAI's new power segment, repurposing CFM56 engines, could add 30% to company value by 2027, with significant upside if unit deliveries meet targets. The stock is rated Buy, with a $393 price target (57% upside) based on 25 power units sold in 2027; risk increases as FTAI enters the…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DNA.
U.S. House Trading
No House trades found for DNA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.